StemCell Therapy

Burnley wore a one-off all white fourth strip in the win over West Ham United on Wednesday night.

The Clarets have produced the strip after the Premier League flagged a colour clash between the two sides.

Burnleys home and away strips are a natural clash with the Hammers claret and blue kit while the Turf Moor sides green third kit has been deemed a clash by the Premier League system, which does take into account the impact on colour blind viewers.

The league try to ensure four different colours between the two teams - outfielders and goalkeepers - to ensure a contrast.

This includes avoiding a clash of red and green where possible, something that assists viewers watching the game who are colour blind.

The Premier League said Burnley were notified last summer in advance of the season starting that a new kit would be required and a white strip was agreed.

Burnley were able to play in green at Aston Villa as there was sufficient contrast on Villas shirt whereas West Hams is deemed all Claret - hence the change.

And the Clarets have a 100 per cent record in their new kit after Jay Rodriguez's goal gave them all three points.

Colour blindness, or colour vision deficiency, is one of the worlds most common genetic conditions but it is under-recognised and poorly understood. Worldwide, about 320 million people have some form of colour blindness and in the UK there are almost three million colour-blind people. Men are more likely to be colour blind than women, as approximately one in 12 men (8 per cent) inherit red/green colour blindness but only 1 in 200 (0.5%) of women do.

As a result colour-blindness leads to issues in football for people who are colour-blind, including kit clashes between players, goalkeepers, match officials, the playing surface; equipment such as match balls; venues, information and also TV coverage of the match itself.

Go here to see the original:
Why Burnley wore a white kit in their Premier League match with West Ham - Accrington Observer

Diabetes can affect many parts of your body, including your skin. When diabetes affects the skin, its often a sign that your blood sugar (glucose) levels are too high. This could mean that:

You have undiagnosed diabetes, or pre-diabetes

Your treatment for diabetes needs to be adjusted

If you notice any of the following warning signs on your skin, its time to talk with your doctor.

This skin condition often begins as small raised solid bumps that look like pimples. As it progresses, these bumps turn into patches of swollen and hard skin. The patches can be yellow, reddish, or brown.

You may also notice:The surrounding skin has a shiny porcelain-like appearance

A dark patch (or band) of velvety skin on the back of your neck, armpit, groin, or elsewhere could mean that you have too much insulin in your blood. This is often a sign of prediabetes.The medical name for this skin condition is acanthosis nigricans.

Often causing darker skin in the creases of the neck, AN may be the first sign that someone has diabetes.

When this develops on the fingers, toes, or both, the medical name for this condition is digital sclerosis.

On the hands, youll notice tight, waxy skin on the backs of your hands. The fingers can become stiff and difficult to move. If diabetes has been poorly controlled for years, it can feel like you have pebbles in your fingertips.

Hard, thick, and swollen-looking skin can spread, appearing on the forearms and upper arms. It can also develop on the upper back, shoulders, and neck. Sometimes, the thickening skin spreads to the face, shoulders, and chest.

In rare cases, the skin over the knees, ankles, or elbows also thickens, making it difficult to straighten your leg, point your foot, or bend your arm. Wherever it appears, the thickened skin often has the texture of an orange peel.

This skin problem usually develops in people who have complications due to diabetes or diabetes that is difficult to treat.

Its rare, but people with diabetes can see blisters suddenly appear on their skin. You may see a large blister, a group of blisters, or both. The blisters tend to form on the hands, feet, legs, or forearms and look like the blisters that appear after a serious burn. Unlike the blisters that develop after a burn, these blisters are not painful.

Large blisters like this one can form on the skin of people who have diabetes.

The medical name for this condition is bullosis diabetricorum. Sometimes, its called diabetic bullae.

People who have diabetes tend to get skin infections. If you have a skin infection, youll notice one or more of the following:Hot, swollen skin that is painful

Has it been a year or longer since your last period, and do you get several yeast infections each year? Its possible that you have diabetes or pre-diabetes.

Having high blood sugar (glucose) for a long time can lead to poor circulation and nerve damage. You may have developed these if youve had uncontrolled (or poorly controlled) diabetes for a long time.

Poor circulation and nerve damage can make it hard for your body to heal wounds. This is especially true on the feet. These open wounds are called diabetic ulcers.

If you have diabetes, you should check your feet every day for sores and open wounds.

This skin condition causes spots (and sometimes lines) that create a barely noticeable depression in the skin. Its common in people who have diabetes. The medical name is diabetic dermopathy. It usually forms on the shins. In rare cases, youll see it on the arms, thighs, trunk, or other areas of the body.

Diabetic dermopathy: This 55-year-old man has had diabetes for many years.

The spots are often brown and cause no symptoms. For these reasons, many people mistake them for age spots. Unlike age spots, these spots and lines usually start to fade after 18 to 24 months. Diabetic dermopathy can also stay on the skin indefinitely.

When these bumps appear, they often look like pimples. Unlike pimples, they soon develop a yellowish color. Youll usually find these bumps on the buttocks, thighs, crooks of the elbows, or backs of the knees. They can form anywhere though.

These bumps appear suddenly and clear promptly when diabetes is well-controlled.

When these bumps appear, they often look like pimples. Unlike pimples, they soon develop a yellowish color. Youll usually find these bumps on the buttocks, thighs, crooks of the elbows, or backs of the knees. They can form anywhere though. No matter where they form, they are usually tender and itchy. The medical name for this skin condition is eruptive xanthomatosis.

Whether this skin condition is associated with diabetes is controversial. We know that most people who have granuloma annulare do not have diabetes. Several studies, however, have found this skin condition in patients who have diabetes. One such study found that people with diabetes were most likely to have granuloma annulare over large areas of skin and that the bumps came and went. Another study concluded that people who have granuloma annulare that comes and goes should be tested for diabetes.

This skin condition causes bumps and patches that may be skin-colored, red, pink, or bluish purple.

If you have diabetes, youre more likely to have dry skin. High blood sugar (glucose) can cause this. If you have a skin infection or poor circulation, these could also contribute to dry, itchy skin.

These develop when you have high fat levels in your blood. It can also be a sign that your diabetes is poorly controlled.The medical name for this condition is xanthelasma.

Many people have skin tagsskin growths that hang from a stalk. While harmless, having numerous skin tags may be a sign that you have too much insulin in your blood or type 2 diabetes.

These growths are most common on the eyelids, neck, armpit, and groin.

Diabetes can cause many other skin problems. Most skin problems are harmless, but even a minor one can become serious in people who have diabetes. A board-certified dermatologist can recognize skin problems due to diabetes and help you manage them.

ImagesImage 1: Image Courtesy of Clark C. Otley, MD. All Rights Reserved

Images 3, 7, 8, 9: Used with permission of the American Academy of Dermatology National Library of Dermatologic Teaching Slides.

Image 2 from DermNetNZ

Some images used with permission of Journal of the American Academy of Dermatology

Images 5, 6 and 10: Getty Images

ReferencesCohen Sabban, EN. Cutaneous manifestations of diabetes mellitus from A to Z. Focus session presented at: 74th Annual Meeting of the American Academy of Dermatology; March 4-8, 2016; Washington D.C.

Duff M, Demidova O, et al. Cutaneous manifestations of diabetes mellitus. Clinical Diabetes. 2015;33:40-8.

Kalus AA, Chien AJ, et al. Diabetes mellitus and other endocrine disorders. In: Wolff K, Goldsmith LA, et al. Fitzpatricks Dermatology in General Medicine (seventh edition). McGraw Hill Medical, New York, 2008:1461-70.

McKinley-Grant L, Warnick M, et al. Cutaneous manifestations of systemic disease. In: Kelly AP and Taylor S. Dermatology for Skin of Color. (first edition). The McGraw-Hill Companies, Inc. China, 2009:481-4.

Morgan AJ and Schwartz RA. Diabetic dermopathy: A subtle sign with grave implications. J Am Acad Dermatol. 2008;58:447-51.

Yosipovitch G, Loh KC, et al. Medical pearl: Scleroderma-like skin changes in patients with diabetes mellitus. J Am Acad Dermatol. 2003;48:109-11.

Here is the original post:
Diabetes: 12 warning signs that appear on your skin

Doctor making blood sugar test in clinic. Blood sugar measurement in a medical clinic

Its enough that SARS-CoV-2, the virus that causes Covid-19, can cause pneumonia, kidney failure, blood clots, arrhythmias and even heart attacks, but the potential that the virus may also lead to onset of diabetes provides a new set of implications and potential complications for survivors.

A recent report in Nature details the rationale and proposed mechanisms behind the ability of the virus to damage specialized cells in the pancreas that make insulin, otherwise known as beta cells, contained in surrounding specialized cells (islets).

When beta cells are destroyed, and the body is unable to manufacture insulin, a person develops elevated blood sugar, known as hyperglycemia, which effectively switches the body to an alternate pathway for energy using ketones and ketone bodies as a primary source. Using ketones bodies for energy will trigger a dangerous state where the body produces harmful acids, leading to diabetic ketoacidosis (DKA), which can be fatal if left untreated.

Whats clear is that diabetes is already recognized as a key risk factor for developing severe Covid-19, and persons with this condition have a higher risk of death.

But new research is emerging that the virus not only causes a more severe course in diabetics, but may also trigger onset of the condition in a subset of patients. The potential for a crush of patients with new onset diabetes (Type 1) may be a new reality that the medical community is yet to face.

Clinicians are now seeing previously well people with no history of diabetes who have suddenly developed new onset diabetes after being infected with SARS-CoV-2, along with the dangerous complication, DKA, in which people develop acid in their blood stream, accompanied by rapid breathing, which can lead to shock and death.

If we look back at patients who developed SARS back in 2002-2003, there is a linkage with development of autoimmune conditions such as type 1 diabetes. We also know that many organs which play a role in regulation of blood sugarthe liver, pancreas, kidneys, small intestine and adipose tissue (fat) have a large number of ACE-2 receptors, the receptor on the surface of cells that the virus attaches to using its spike protein. Thats said, the basis for onset of ketosis-prone diabetes following infection with influenza or herpes has been previously reported in the medical literature.

Additional research recently published using miniature lab grown pancreases also suggests that the virus may cause diabetes by injuring the specialized cells, beta cells, that regulate blood sugar.

That said, other researchers have been less convinced about the strength of the connection between Covid-19 and new onset or worsening of diabetes.

We need to keep an eye on diabetes rates in those with prior COVID-19, and determine if rates go up over and above expected levels, said Naveed Sattar, a metabolic-disease researcher at the University of Glasgow, UK in the Nature report.

Clearly, more rigorous studies will be necessary to more definitively establish this link.

That said, a new collaborative research endeavor, the CovDiab Registry, was recently established by a group of researchers to study the presentation and spectrum of illness of patients with newly developed diabetes or complications related to existing diabetes.

The Registry will be useful, the researchers believe, in order to determine not only causes, but whether the diabetic state as a result of Covid-19 is permanent. Another goal will also be to look at those who are pre-diabetic and determine whether Covid-19 accelerates the pathway to Type 2 DM.

In fact, a letter published last month in theNew England Journal of Medicineand signed by an international group of 17 leading diabetes experts involved in the CoviDiab Registry project, announced the establishment of the Global Registry of new cases of diabetes in patients with COVID-19.

Clinical observations thus far demonstrate a bi-directional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with increased risk of Covid-19 severity and mortality. Between 20 and 30% of patients who died with Covid-19 have been reported to have diabetes. At the same time, new-onset diabetes and life threatening metabolic complications of pre-existing diabetes such as DKA have also been in people with Covid-19.

"Diabetes is one of the most prevalent chronic diseases and we are now realizing the consequences of the inevitable clash between two pandemics, said Francesco Rubino, Professor of Metabolic Surgery at King's College London and co-lead investigator of the CoviDiab Registry project in a press release. Given the short period of human contact with this new coronavirus, the exact mechanism by which the virus influences glucose metabolism is still unclear and we don't know whether the acute manifestation of diabetes in these patients represent classic type 1, type 2 or possibly a new form of diabetes."

One research group at Weill Cornell Medicine in New York City believes that the virus may directly damage the pancreas itself. Using so called organoids, miniature artificial lab- grownorgans, Shuibing Chen and her team demonstrated that the virus can infect beta cells (which make insulin) a portion of which die. The virus seems to also induce production of cytokines which can trigger whats believed to be an inflammatory response that can lead to death of beta cells.

We certainly dont have all the answers just yet. While the organoid study does add some strength to the premise that SARS-CoV-2 may either cause or make existing diabetes worse, this research is still not enough to establish a definitive link, let alone causation.

Its certainly possible that SARS-CoV-2 could produce a heightened inflammatory state which could inhibit the ability of the pancreas to accurately detect glucose and release insulin, while diminishing the capacity and ability of the liver to sense insulin. The end result could potentially lead to diabetes. That said, severe fatigue and muscle atrophy or breakdown could place people at risk for pre-diabetes into a diabetic state.

Long term studies will be essential to better understand the multiple potential mechanisms involved. Stay tuned!

Full coverage and live updates on the Coronavirus

The rest is here:
Can Covid-19 Trigger The Onset Of Diabetes? - Forbes

Study after study has shown that excessive consumption of highly processed carbs and sugar can put a person at risk of developing type 2 diabetes. The trick is finding satisfying substitutes for that soda and white bread. We suggest the following.

Replacing Sugar In Your Diet

A discussion regardingweight loss or a healthier body normally prompts a discussion on how to reduce sugar consumption.Even eatingfruits and vegetables has prompted healthy exchanges among experts.

As such, here are reasonsto cut back on sugar, and substitutes for it:

Replace sugar with natural sources

Despite the controversy over whether natural sugar is any less harmful than the processed kind, the least complicatedway to cut back on sugar is byreplacing it with a natural alternative. Jaggery, for example, can be added to both tea and coffee.

Opt for detox water over sodas

A 2010 Diabetes Care study found that those who drank sugar-laden drinks, 1 to 2 servings a day, had a 26 percent greater chance of developing diabetes than those who drank one serving or less a month. Drink detox water instead, which is made by infusing water with crushed fruits and vegetables for some added flavor.

Bag the can

Canned fruits usually contain syrup, which also has sugar. Instead, buy fresh fruitsfor a healthier alternative.

Hide the sugar bowl

Dont want sugar? Then remove it from the dining table. Out of sight, out of ....

Munch on whole foods

A 2007 Archives of Internal Medicine study conducted among Chinese women found that those who ate foods containing highly processed carbohydrates had a 21 percent greater chance of developing type 2 diabetes than those in the group who ate whole foods.Additionally, theyalso keep you feeling satedfor longer, helping you avoid munching on those snacks sitting on top of your trefrigerator.

Both white and brown sugar came from either the sugarcane or sugar beet plant but they have different properties. Pixabay

Visit link:
Carbs, Sugar and Threat of Diabetes: Reduce Consumption, Reduce Type 2 Risk - Medical Daily

Hyperglycemia occurs when a person with diabetes has too much sugar in their bloodstream. The underlying cause of hyperglycemia is due to a loss of insulin producing cells in the pancreas or when the body develops resistance to insulin. The condition can become dangerous when blood glucose levels stay high for extended periods of time which could lead to the development of long-term complications. Eating the right kinds of food to help stabilise blood sugar levels is well known but what about certain drinks.

Diabetes insipidus is a rare form of diabetes that is not related to blood sugar-related diabetes mellitus but does share some of its signs and symptoms saidDiabetes.co.uk.

The websitecontinued: Diabetes insipidus is simply excessive urination and complications thereof, caused by an antidiuretic hormone called vasopressin.

Diabetes insipidus leads to frequent urination, and this is the most common and clear symptom.

A secondary symptom is increased thirst, as a result of passing so much water and if this is not met, then dehydration can occur which can lead to cracked skin, fatigue, confusion, dizziness and unconsciousness.

There are a variety of factors which contribute to the onset of type 2 diabetes but one of the most common is consuming a large amount of calories throughout the day, especially from added sugars which are found in many foods and, notably, in beverages.

Diabetics are strongly advised to monitor their calorie intake which is often overlooked by the drinks consumed.

Diabetics are recommended to minimise their calories and opting for pure, plain water which contains zero calories is always the best option.

Water does not raise a persons blood sugar levels and studies have shown that when a diabetic has too high a blood glucose level, drinking water enables more glucose to be flushed out of the bloodstream.

Experts agree that water should be the main source of hydration for type 2 diabetes.

If youre consistently dehydrated on a daily basis, you might even be compensating with higher insulin levels than youd need if your body was getting the water it needed, said Diabetes Strong.

The health site added: Its the simple issue of severe dehydration causing the glucose in your bloodstream to become extremely concentrated, and then quickly diluting it with plenty of fluids.

Water actually does far more for our bodies than we realise.

Water aids digestion, lubricates joints, helps flush waste products and performs a host of other important tasks in our body.

See the original post:
Type 2 diabetes: The best drink to consume to help lower blood sugar - Express

Diabetes UKs Chief Executive Chris Askew said a letter signed by more than 12,000 people is calling for the Government to support clinically vulnerable people at work.

The organisation wants more robust protections and safety measures to be put in place to protect those with diabetes and other chronic health conditions.

Last week it was announced that shielding measures were to be eased and the 2 metre social distancing rule was to be reduced to just one.

Diabetes UK said that 64 per cent of the public think the Government should be doing more to protect those at work who have underlying health conditions.

Caroline, from London, has type 2 diabetes and has been constantly worried about her health throughout the pandemic.

The 60-year-old said: I work in a small local supermarket where social distancing just isnt possible and my diabetes is not on the companys list of conditions for people that should be furloughed.

Speak to other people with diabetes:

I tried my best to keep the 2 metre distance, but no one seems to care. Now that it is 1m+ Ive given up entirely. My stress levels have become unmanageable and Ive decided to cut back my hours to try and stay as safe as possible.

I will be losing out financially but if it is between my life or a paycheque I know which one I choose.But some arent so lucky to be able to make that decision and the Government need to consider that.

Mr Askew said: The message from people with diabetes is clear; we want to go about our lives, but were deeply worried about our health as lockdown eases, and we want to know were going to be protected.

Related to this topic:

But what is also clear is that with the next stage of the re-opening of the UK imminent the needs of people with diabetes are not being properly considered. People with long term conditions cannot, and should never have been the Governments blind spot. Lives are at stake.

We reiterate our calls, which we have been doing for weeks, to ensure that people with diabetes are not forgotten, and that additional measures and safeguards are in place and enforced to keep them safe.

In the UK there are 3.9 million people with diagnosed diabetes who were identified as being clinically vulnerable by the Government. From Saturday, July 4, the official advice is those people can meet others outdoors but should be especially careful and be diligent about social distancing and hand hygiene.

Go here to read the rest:
Charity urges Government to step in and protect those with diabetes - Diabetes.co.uk

DUBLIN--(BUSINESS WIRE)--The "Diabetic Retinopathy Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Certain factors that are driving the market growth include the rising prevalence of diabetes and blindness due to the same, growing geriatric population base, increasing technological advancements in diabetic retinopathy surgical instruments.

There is an increasing burden of diabetic retinopathy across the globe. As stated by the International Diabetes Federation (IDF), the global prevalence of DR from 2015 to 2019 was around 27%. The lowest prevalence was in Europe at 20.6% and South East Asia at 12.5% and highest in Africa at 33.8%, Middle East and North Africa 33.8%, and the Western Pacific region at 36.2%.

Hence, the rising prevalence of DR, along with the growing awareness and concern over it, are expected to drive the market growth over the forecast period.

Key Market Trends

Proliferative diabetic retinopathy is Expected to Hold Significant Market Share in the Type Segment

Proliferative diabetic retinopathy (PDR): PDR is the most advanced stage of diabetic retinopathy. At this stage, circulation problems deprive the retina of oxygen. As a result, new, fragile blood vessels can begin to grow in the retina and into the vitreous, the gel-like fluid that fills the back of the eye. The new blood vessels may leak blood into the vitreous, clouding vision.

Symptoms include progressive loss of vision, particularly in those who are not properly followed or treated. The major risk factors for PDR include the duration of diabetes, since 30-34 years of diabetes increase the risk of retinopathy by 65%, according to the reports published by the Columbia University. Hence, the rising prevalence of diabetes is directly contributing to a further increase in the prevalence of PDR.

North America Dominates the Market and Expected to do Same in the Forecast Period

Over the past decade, the prevalence of diabetes in North America has increased. People with diabetes are at risk for diabetic retinopathy. Diabetic retinopathy is the leading cause of new cases of blindness among adults aged 20 to 74 years in the United States. More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a new report published by the Centers for Disease Control and Prevention (CDC). Hence with the increasing number of people living with diabetes is expected to contribute to market growth across the entire region.

Competitive Landscape

The global Diabetic Retinopathy market is moderately competitive and consists of a few major players. Companies like Alimera Sciences, Allergan plc, BCN Peptides, Genentech, Glycadia Pharmaceuticals, Kowa Group, Novartis AG, Oxurion N.V., Regeneron Pharmaceuticals Inc, among others, which hold the substantial market share in the Diabetic Retinopathy market.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Prevalence of Diabetes and Blindness due to the Same

4.2.2 Growing Geriatric Population Base

4.2.3 Increasing Technological Advancements in Diabetic Retinopathy Surgical Instruments

4.3 Market Restraints

4.3.1 Lack of Skilled Ophthalmologists

4.3.2 Extended Approval Time for Drugs

4.4 Porter's Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Type

5.1.1 Proliferative Diabetic Retinopathy

5.1.2 Non-proliferative Retinopathy

5.2 By Management Approach

5.2.1 Anti-VEGF Drug

5.2.2 Intraocular Steroid Injection

5.2.3 Laser Surgery

5.2.4 Vitrectomy

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle-East & Africa

5.3.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Alimera Sciences

6.1.2 AbbVie Inc. (Allergan plc)

6.1.3 BCN Peptides

6.1.4 Genentech

6.1.5 Glycadia Pharmaceuticals

6.1.6 Kowa Group

6.1.7 Novartis AG

6.1.8 Regeneron Pharmaceuticals Inc

6.1.9 Oxurion N.V.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/w4r3ha

More:
World Diabetic Retinopathy Market 2020-2025 - Rising Prevalence of DR Along With Growing Awareness and Concerns - ResearchAndMarkets.com - Business...

Most people would be shocked to learn that more than 34 million Americans are living with diabetes. That figure represents more than 10% of the countrys population. Sadly, more than 200,000 children in the United States have diabetes.

Numerous companies are hard at work developing diabetes treatments and tools that relieve the pain of this deadly disease. DexCom (DXCM), Livongo Health (LVGO), and Tandem Diabetes Care (TNDM) are three companies involved in diabetes care that you should keep an eye on as we transition to the second half of 2020.

DexCom(DXCM)

Glucose monitoring systems are helping people with diabetes across the globe. DXCM makes these systems for ambulatory use by diabetics and healthcare providers that treat both diabetic patients and non-diabetic patients. The technology measures the patient blood glucose level continuously by transmitting the information to a smartphone. Nearly 700,000 patients were using DXCM glucose monitoring systems as of the start of 2020.

Now that diabetes impacts more people than ever before, DXCMs blood glucose monitoring technology will prove quite valuable. The economic recession should not impact the demand for DXCMs diabetes products, as these tools can make the difference between life and death.

It will surprise no one that DXCM is one of the top-rated stocks in our momentum-basedPOWR Ratings system. Overall, it is the #1 ranked stock in the #10 ranked industry (Medical Devices & Equipment Stocks).

Livongo Health(LVGO)

Every diabetic patient can benefit from reminders to help them manage their disease. LVGO provides this type of information in a high-tech and reliable manner and that is only one segment of LVGOs product offerings. LVGO also provides various sorts of digital health tools, including a platform that uses technology and data science to help people battling chronic conditions.

As time progresses, more and more businesses will be tapping into LVGOs services. LVGO management forecasts year-over-year growth upwards of 110% or more. As LVGO member enrollment continues to increase, the stock could reach new heights. LVGO is up nearly 300% year-to-date.

LVGO has 4 Aces up its sleeve. By that I mean that all 4 out of 5 scores in our POWR Ratings system is an A for the stock. It is also the #5 ranked stock in theMedical Servicesindustry.

Tandem Diabetes Care(TNDM)

It is not often that you find a company making it through the pandemic and recession without a meaningful hit to its operations. TNDM is one of those companies. TNDM executives issued a press release in mid-March, stating its warehouse and manufacturing facilities would continue operating as usual amidst the pandemic.

TNDM sales were just under $98 million during the first quarter of 2020. This figure represents a near 50% rise on a year-over-year basis. TNDMs insulin pump sales grew by nearly 20% during that same period. The company recently agreed to a deal with Abbott Laboratories to provide patients withenhanced diabetes managementtools.

How does TNDM stack up for the POWR Ratings?

A for Trade Grade

A for Buy & Hold Grade

B for Industry Rank

A for Peer Grade

A for overall POWR Rating

It is also the #10 rated stock in the Medical Services industry.

Want More Great Investing Ideas?

9 BUY THE DIP Growth Stocks for 2020

Is the Bull S#*t Rally FINALLY Over?

7 Safe-Haven Dividend Stocks for Turbulent Times

Top 3 Investing Strategies for 2020

DXCM shares were trading at $429.85 per share on Wednesday afternoon, up $3.99 (+0.94%). Year-to-date, DXCM has gained 96.51%, versus a -1.48% rise in the benchmark S&P 500 index during the same period.

Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...

See the original post:
DXCM: 3 Top Diabetes Stocks for the Second Half of 2020 - StockNews.com

Diabetes management requires management of blood sugar levels

Diabetes diet should include foods that can help in stabilisingblood sugar levels. Glycemic index is a commonly used tool that helps determine foods that are safe for consumption by diabetics. It is a value that is used to measure how specific food affects blood sugar levels. It helps you understand how fast your body converts the carbs present in the food into glucose. Two foods with the same amount of carbs can have different glycemic index numbers.

Your diet must include lots of vegetables.They are loaded with essential nutrients and fibre that are beneficial for the body. Vegetables with low GI can be a part of a diabetes diet. The lower the GI number, the lesser is the impact on blood sugars. There are three GI ratings- low GI: 55 or less, Medium GI- 56-69 and High GI- 70 or above. Here's a list of vegetables with low GI that diabetes can add to their diet.

Broccoli is a non-starchy vegetable that contains very few carbs. This green vegetable is loaded with essential nutrients that can beneficial for your overall health in several ways. It is alsolow in calories.

Broccoli is loaded with water and fibrePhoto Credit: iStock

Tangy tomatoes are also beneficial for diabetics. These also have a low-GI ranking. Tomatoes are also good for your heart health. You can add tomatoes to different recipes. These can be consumed both raw and cooked.

Also read:Are You Eating Enough Tomatoes? If Not, Then You Must; Here's Why

Beetroot is a popular root vegetable that contains essential vitamins, plant compounds and minerals. It is low in calories and high in vitamin C that can boost your immunity levels too.

Also read:Beetroot Health Benefits: Weight Loss, Controlled Blood Pressure, Better Digestion And Much More; Know All Benefits Beetroot Can Offer

Spinach is one of the healthiest leafy greens. It is beneficial for diabetics as well as for weight loss. You can add spinach to salads, soups, sandwiches and other recipes. Boiled spinach can also be a part of your diet.

A cup of boiled spinach can help in weight lossPhoto Credit: iStock

Carrots have a GI score of 39. Carrots contain protein and fibre. Carrot veggie sticks are a healthy snack you can try to beat hunger pangs in the evening.

Also read:Carrot Juice Health Benefits: Health Coach Luke Coutinho Tells Why You Must Include It In Your Diet

Vegetables are power-packed with nutrients. Diabetics should first consume in moderation. Later, you may consult your doctor to know the exact quantity that suits your diet. Number of carbs also affects the blood sugar levels. GI also has certain limitations as it may vary in cooked and raw form of the same vegetable.

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

See the original post here:
Diabetes Diet: 5 Low-Glycemic Vegetables Diabetics Must Add To Their Diet - NDTV

Spectrum Generations in partnership with Healthy Living for ME will be offering a free workshop to help individuals with diabetes, prediabetes, their caregivers or family members. Living Well with Diabetes will be offered beginning Monday, August 13 and running through September 17. Workshops participants will meet weekly from 9:30 - 11:30 a.m.

Topics such as testing your blood sugar, menu planning, stress management, increasing activity level, treating low blood sugar, caring for your feet, and healthy eating will be discussed.

This series is free and open to the public but registration is required. Please call (207) 620-1642 or emailjpaquet@healthylivingforme.orgfor more information and to register. Technical support is available.

Healthy Living for ME is a statewide network of evidence-based programs that empower adults to address and better manage their health issues. All workshops are listed athealthylivingforme.org.

About Spectrum GenerationsSpectrum Generations, the Central Maine Area Agency on Aging and Aging and Disability Resource Center, has been a leading provider of information and advice, referrals, programs and activities for adults for over 30 years. Todays Spectrum Generations is poised to serve adults of all ages and backgrounds in a changing, challenging world. We are here for you as you look forward to longer, more active lives and seek to engage in new physical and intellectual challenges.

About Healthy Living for MEHealthy Living for ME brings together Spectrum Generations, SeniorsPlus, and Aroostook Agency on Aging three of Maines Area Agencies on Aging in a partnership to deliver statewide chronic disease self-management and falls prevention classes. FMI or to find a class, visit:healthylivingforme.orgor on Facebook @HLforME

Read this article:
Free diabetes, nutrition program offered through Zoom - PenBayPilot.com

Diabetes diet management: Here are 7 foods with high GI that diabetics must avoid to balance blood sugar  |  Photo Credit: iStock Images

New Delhi: Diabetes has already reached epidemic levels around the world. With a rise in chronic diseases such as heart health issues, kidney diseases, and diabetes, it becomes extremely important to take care of what we eat. People who already suffer from diabetes not only need to keep a regular check on their blood sugar, but also need to be very mindful of what they need, not just in terms of how many spoons of sugar they add to their tea or coffee, but also with respect to other properties of food, such as the Glycemic Index.

To determine the intensity of sweetness, and sugar content of foods, a unit called the Glycemic Index has been devised. The Glycemic Index is a relative ranking of carbohydrate in foods according to how they affect their blood sugar levels. GI is one of the most important considerations for diabetics when it comes to managing their diet. These GI values of 5 most common foods consumed by people worldwide, and how they are likely to affect blood sugar levels for diabetics can help diabetes manage their diet better.

Cutting off unnatural sources of sugar like crystalized sugar, syrup, etc from your diet is recommended to stay healthy, keep your weight in check. If you have diabetes, it is recommended to cut off all sources of sugar, especially processed and unnatural sources. However, natural sources of sugar are unlikely to harm your health, but being aware of their sugar content can help you manage your condition better.

Disclaimer: Tips and suggestions mentioned in the article are for general information purposes only and should not be construed as professional medical advice. Always consult your doctor or a professional healthcare provider if you have any specific questions about any medical matter.

See the article here:
Diabetes diet management: Here are 7 foods with high GI that diabetics must avoid to balance blood sugar - Times Now

Add fruit, veggies and grains to diet to reduce type 2 diabetes risk

London, July 9 (IANS) Higher consumption of fruit, vegetables and whole-grain foods are associated with a lower risk of developing type 2 diabetes, say researchers.

The findings, published in the journal The BMJ, suggest that even a modest increase in consumption of these foods as part of a healthy diet could help prevent type 2 diabetes.

In the first study, a team of European researchers examined the association between blood levels of vitamin C and carotenoids (pigments found in colourful fruits and vegetables) with the risk of developing type 2 diabetes.

Vitamin C and carotenoid levels are more reliable indicators of fruit and vegetable intake than using dietary questionnaires.The research team compared 9,754 adults with new-onset type 2 diabetes to a group of 13,662 adults who remained free of diabetes.

The researchers calculate that every 66 grams per day increase in total fruit and vegetable intake was associated with a 25 per cent lower risk of developing type 2 diabetes.

In the second study, the research team used questionnaires to measure the whole grain intake of more than 158,000 women and nearly 37,000 men who were free from diabetes, heart disease and cancer.

After adjusting for lifestyle and dietary risk factors for diabetes, participants in the highest category for total whole grain consumption had a 29 per cent lower rate of type 2 diabetes compared with those in the lowest category.

For individual whole-grain foods, the researchers found that consuming one or more servings a day of whole-grain cold breakfast cereal or dark bread was associated with a lower risk of type 2 diabetes compared with consuming less than one serving a month.

The findings showed that eating two or more servings a week of oatmeal was associated with a 21 per cent lower risk of diabetes, a 15 per cent lower risk for added bran and a 12 per cent lower risk for brown rice and wheat germ, when compared to eating less than one serving a month.

And for fruit and vegetables, the findings also suggest that consumption of even a moderately increased amount among populations who typically consume low levels could help to prevent type 2 diabetes.

--IANS

bu/arm

See the original post:
Add fruit, veggies and grains to diet to reduce type 2 diabetes risk - Outlook India

According to a new population-based cohort study, over three-quarters of patients with type 2 diabetes (T2D) in England have at least one other physical or mental health condition. The findings were published in the journal BMJ Open .

Researchers compared 108,588 T2D patients with 528,667 individuals without T2D, registered in English general practices. They analysed the annual patterns of several physical and mental health conditions among individuals with and without T2D.

The findings showed that 77%of individuals with T2D had one or more physical or mental health comorbidity. Individuals with T2D had a 2.4-fold, 1.8-fold, 1.6-fold and 1.6-fold higher likelihood of having schizophrenia, depression, asthma and chronic obstructive pulmonary disease (COPD), respectively, compared with individuals without T2D. Individuals with T2D had twice the prevalence of cardiovascular disease than their non-T2D counterparts. Additionally, osteoarthritis, hypothyroidism and anxiety were also more prevalent in individuals with T2D.

The lead author, Dr Salwa Zghebi, said: "We highlight the need for future clinical guidelines in diabetes to refocus patient-centred care on non-cardiometabolic conditions such as asthma, COPD, anxiety, depression, schizophrenia, and osteoarthritis."

"Mental health is of particular concern and our data highlight a profound clinical need in young people with type 2 diabetes who might benefit enormously from mental health interventions," she added.

Zghebi SS, Steinke DT, Rutter MK, Ashcroft DM. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data. BMJ Open. 2020;10(7):e033866. doi: 10.1136/bmjopen-2019-033866. PMID: 32611677. Full text.

This article originally appeared on Univadis, part of the Medscape Professional Network.

Read the original:
Three-quarters of Patients with Type 2 Diabetes Have Other Comorbidities - Medscape

(MENAFN - GetNews) According to report published by Grand View Research, Growing awareness over diabetes coupled with preventive measures taken by consumers is anticipated to spur the market growth.

The global diabetic food market size is expected to reach USD 11.76 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for diabetic food in the medical sector is anticipated to fuel the market growth.

Diabetic Food is the diet which is recommended for individuals with high blood glucose or diabetes mellitus. It usually consists of edible products which are rich in refined carbohydrates and have low sugar content. Different individuals living with diabetes are recommended different types of diet based on their condition. In cases of hypoglycemia many are recommended to have a diet which increases their blood glucose level rapidly and in other cases, individuals suffering from diabetes mellitus are recommended to have a diet which reduces their high glycemic index (GI) carbohydrates intake.

Major technological shifts in the manufacturing processes and the use of advanced machinery are anticipated to positively affect the market growth. Many firms are investing in creating android and iPhone applications to help the individuals living with diabetes to better manage their health. These applications include BG Monitor Diabetes, Blue Loop, Calorie Counter PRO, Diabetes in Check and Diabetes Tracker. These applications help people to set reminders, create graphs and spreadsheets of their data, calculate their calorie intake, insulin requirements and track their progress.

The diabetic food industry is governed by various regulations that cover the entire lifecycle ranging from production to end use. Diabetic products used in the healthcare industry need to strictly abide by the stringent U.S. FDA regulations. Health disorders are a result of unhealthy lifestyles such as long working hours, sedentary lifestyle, smoking, poor food habits and alcohol consumption and are anticipated to influence the industry growth over the forecast period.

U.S. diabetic food market revenue by application, 2014 - 2025 (USD Million)

Request a sample Copy of the Diabetic Food Market Research Report @ https://www.grandviewresearch.com/industry-analysis/diabetic-food-market/request/rs1

Key Takeaways Of The Report :

The global diabetic food demand was USD 7 billion in 2015 and is estimated to grow at a CAGR of 5.4% from 2016 to 2025

Demand in dairy application is estimated to exceed USD 3 billion by 2025, owing to its probiotic properties

Baked products application segment is estimated to grow at a CAGR of 5.5% over the forecast period owing to the large demand of sugar-free baked products by health conscious consumers

Product demand in Asia Pacific is expected to grow at a significant rate of 6.0% over the next nine years owing to the emerging economies and the growing investment in the medical foods sector

Diabetic foodmarket in North America is anticipated to exceed USD 4 billion by 2025, owing to the growing medical sector and imbalance in work life and unhealthy lifestyle

Companies such as Coca-Cola Company and PepsiCo Inc. offer raw materials including, dietary syrups, carbon dioxide, sweeteners, and juices, to various industries including, frozen foods, nutritional and functional foods, beverages, medical and processed foods.

Business expansions by companies, such as Mondelz International to establish global research, development & quality (RDQ) network of the future, is anticipated to strengthen the market presence over the coming years

Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/1906/ibb

Global diabetic food market revenue by region, 2015 (USD Million)

Grand View Research has segmented the global diabetic food market on the basis of product, application, and region:

Diabetic Food Market, Application Outlook (Revenue, USD Million, 2014 - 2025)

Diabetic Food Market, Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

Europe

Asia Pacific

CSA

MEA

Grasp advance knowledge on Diabetic Food Market through in-depth Blogs, Research Insights:

Access Blog " https://www.grandviewresearch.com/blog/diabetic-food-market-size-share "

Media Contact Company Name: Grand View Research, Inc. Contact Person: Sherry James, Corporate Sales Specialist - U.S.A. Email: Send Email Phone: 1-415-349-0058, Toll Free: 1-888-202-9519 Address: 201, Spear Street, 1100 City: San Francisco State: California Country: United States Website: https://www.grandviewresearch.com/industry-analysis/diabetic-food-market

Follow this link:
Diabetic Food Market Size Predicted To Reach USD 11.76 Billion By 2025 | Grand View Research Inc. - MENAFN.COM

The fraternity of baseball players with type 1 diabetes isnt large. Its not unusual for someone to make a connection with someone else through a mutual friend within the group. Thats how former major-league outfielder Sam Fuld remembered getting in touch with Garrett Mitchell a few years ago.

Mitchell, 21, was in high school, a top outfield prospect preparing to attend UCLA, when he first heard from Fuld. One day, Fuld, whose eight-year playing career ended in 2015, phoned him. They shared stories. Fuld was diagnosed with type 1 diabetes when he was 10. Mitchell was 9 when he learned he had diabetes. Fuld offered advice. The two have maintained a relationship. Throughout it, Fuld has learned how well-equipped Mitchell is at handling the disease.

I was impressed with him right away, Fuld said. Just talking to him, he seemed like a mature kid back then. He certainly seemed to have a really good mindset, which is so key in...

See original here:
Brewers' Garrett Mitchell has unique perspective by living with type 1 diabetes - The Athletic

JDRF, the world's leading type 1 diabetes charity, is partnering with Diabetes UK to find out how the coronavirus pandemic is affecting people with type 1 diabetes.

Whilst risk of death from COVID-19 is low, for people with and without type 1 diabetes, NHS figures nonetheless show the risk is higher for those with the condition.

Scientists dont know how many people with type 1 have had coronavirus and recovered, obscuring the full impact that the virus is having on the UKs 400,000 people with type 1.

Now, JDRF and Diabetes UK will co-fund Professor Kathleen Gillespie, at the University of Bristol, to find out.

Professor Gillespie's team will work with a research group in Milan that has developed a test that can detect coronavirus antibodies in a small sample of blood small enough to be collected via post.

By offering this test to around 5,000 people participating in ongoing studies of type 1 diabetes (the Barts Oxford study and UK TrialNet), Professor Gillespie will be able to estimate how many people contracted coronavirus.

She will also ask participants to share their experiences of COVID-19 and lockdown including whether they have been shielding, if they have had any COVID-19 symptoms, and how their blood glucose levels have reacted.

With this information, Professor Gillespie will be able to see how the type 1 diabetes community has been hit by COVID-19.

This will give scientists and clinicians a clearer idea of the risk that coronavirus poses to people with type 1, enabling healthcare teams to better support and protect people with the condition.

Kathleen Gillespie, Professor of Molecular Medicine at the University of Bristol, said: "Although we know that people with type 1 diabetes are at greater risk if they develop COVID-19, we know very little about how this translates to peoples experiences of the pandemic.

"With this research, we hope to get a much clearer idea of how the type 1 diabetes community has been affected by coronavirus, and how they can be kept safe and well in future."

Rachel Connor, Director of Research Partnerships at JDRF, said: "Everyone with type 1 diabetes is different, and Professor Gillespies work will shed some much-needed light on the individual experiences behind the statistics.

"Were hopeful that with this information, policymakers and healthcare teams will be able to give people with type 1 diabetes the advice and support they need."

Dr Elizabeth Robertson, Director of Research at Diabetes UK, said: "There's never an easy time to live with diabetes, but the COVID-19 pandemic presents particular challenges for people with type 1. It is vital that we understand how having COVID-19, as well as living in lockdown, affects people with type 1 diabetes so that we can provide them with the best advice and care during this difficult time and in the future.

"We're delighted to join forces with JDRF to fund Professor Gillespie's research, which will help us to do this by giving important insights into the experiences of people with type 1 diabetes during the pandemic."

About JDRF

JDRF is the leading global organisation funding type 1 diabetes research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. To accomplish this, JDRF has invested more than 1 billion since our inception. We collaborate with the most talented minds to develop and deliver a pipeline of innovative therapies to people living with type 1 diabetes. Our staff and volunteers around the globe are dedicated to campaigning for our vision of a world without type 1 diabetes.

For more information, please visit jdrf.org.uk or follow us on Twitter: @JDRFUK.

About type 1 diabetes

About the Bristol UNCOVER group

In response to the COVID-19 crisis, researchers at the University of Bristol formed the Bristol COVID Emergency Research (UNCOVER) Group to pool resources, capacities and research effortsto combat this infection.

BristolUNCOVER includes clinicians, immunologists, virologists, synthetic biologists, aerosol scientists, epidemiologists and mathematical modellers and has links to behavioural and social scientists, ethicists and lawyers and is supported by a large number of junior academic and administrative colleagues.

Follow Bristol UNCOVER on Twitter at:https://twitter.com/BristolUncover

For more information about the University of Bristols coronavirus (COVID-19) research priorities visit:www.bristol.ac.uk/research/impact/coronavirus/research-priorities/

Read more from the original source:
July: Diabetes Kathleen Gillespie | News and features - University of Bristol

The past decade has seen significant advances in type 2 diabetes treatments, yet the long-term impact of these advances is not yet fully appreciated. The risk estimates currently available are derived from data that is more than 10 years old. The insurance industry underwrites customers with diabetes based on a range of factors, medical expertise and various medical studies.

The aim of this research project is to develop a deeper understanding of the risks associated with type 1 or type 2 diabetes, and the impact of recent improved treatments. It is hoped that this research will help the insurance industry appreciate and use current data and studies when considering diabetic risks, and ultimately could support individuals with diabetes to gain better access to insurance.

The call for tenders was issued on 1 June and organisations have until 12pm BST on 13 July to submit their proposals. This commissioned research will be overseen by a project steering group including representation from the IFoAs Diabetes Working Party and partner organisations. Independent academic guidance is also being provided by Cass Business School, City, University of London.

For further information onthis jointly commissioned ARC research project, please visitbit.ly/arcdiabetes

Read the original post:
An analysis of diabetes mortality and morbidity risk - The Actuary

New Jersey, United States,- Verified Market Research sheds light on the market scope, potential, and performance perspective of the Type 2 Diabetes Treatment Market by carrying out an extensive market analysis. Pivotal market aspects like market trends, the shift in customer preferences, fluctuating consumption, cost volatility, the product range available in the market, growth rate, drivers and constraints, financial standing, and challenges existing in the market are comprehensively evaluated to deduce their impact on the growth of the market in the coming years. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the Type 2 Diabetes Treatment market.

The research study includes the latest updates about the COVID-19 impact on the Type 2 Diabetes Treatment sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Leading Type 2 Diabetes Treatment manufacturers/companies operating at both regional and global levels:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

Industrial Analysis:

The Type 2 Diabetes Treatment market report is extensively categorized into different product types and applications. The study has a separate section for explaining the cost of raw material and the revenue returns that are gained by the players of the market.

The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for the Type 2 Diabetes Treatment sector and can help companies in deciphering the optimum business move to reach their desired business goals.

In Market Segmentation by Types of Type 2 Diabetes Treatment, the report covers-

Bytype1

In Market Segmentation by Applications of the Type 2 Diabetes Treatment, the report covers the following uses-

Byapplication1

To get Incredible Discounts on this Premium Report, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=31462&utm_source=3WN&utm_medium=007

The Type 2 Diabetes Treatment market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Type 2 Diabetes Treatment market.

This study analyzes the growth of Type 2 Diabetes Treatment based on the present, past and futuristic data and will render complete information about the Type 2 Diabetes Treatment industry to the market-leading industry players that will guide the direction of the Type 2 Diabetes Treatment market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Type 2 Diabetes Treatment market. Additionally, it includes a share of each segment of the Type 2 Diabetes Treatment market, giving methodical information about types and applications of the market.

Reasons for Buying Type 2 Diabetes Treatment Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Type 2 Diabetes Treatment market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.verifiedmarketresearch.com/product/Type-2-Diabetes-Treatment-Market/?utm_source=3WN&utm_medium=007

In the end, the Type 2 Diabetes Treatment market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the Type 2 Diabetes Treatment market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

See the original post:
Type 2 Diabetes Treatment Market Growth By Manufacturers, Countries, Types And Application, End Users And Forecast To 2026 - 3rd Watch News

The global Opthalmology Pacs market covers a detailed analysis of the market appearances, segmentation, size and progress, market shares, provincial collapses, competitive background, tendencies and several growth strategies for this market. Likewise, the market appearances section of this study describes and defines the complete overview of the Opthalmology Pacs market. The global market report extent segment offers the market revenues, covering both the momentous growth of the industry and anticipating the upcoming market revenue. In addition, global market separations break down into the key sub-areas which gives a better idea about the market size.

Top Leading Key Players are:

Topcon Corporation, IBM corporation, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering and more.

Get Sample Copy of this Report: https://www.adroitmarketresearch.com/contacts/request-sample/608

The report gives the description of the competitive landscape of the market, market dividends, and an explanation of the foremost companies. Momentous financial deals that have molded this industry in the previous years are also documented. The strategies tendencies also highlight the predictable future expansions in the Opthalmology Pacs market and commends approaches.

The Opthalmology Pacs market research report also covers the extensive SWOT analysis, venture return investigation, and speculation attainability investigation. The Opthalmology Pacs market report further describes a complete market dynamic such as opportunities, market drivers, as well as challenges prevalent in the global market to better understand the Opthalmology Pacs market more deeply. In addition to this, the Opthalmology Pacs market report also offers qualitative as well as qualitative analysis of very segment along with its revenues and investment details in the market. The Opthalmology Pacs market research report also describes the leading continents as well as their major countries with the profiles of major players operating across the global market.

Browse the complete report @ https://www.adroitmarketresearch.com/industry-reports/opthalmology-pacs-market

Global Opthalmology Pacs market is segmented based by type, application and region.

Based on Type, the market has been segmented into:

By End-Use, market is segmented into:

HospitalsAmbulatory Surgical Center (ASCS) & Specialty ClinicsOthersBy Type, market is segmented into:

Standalone PACSIntegrated PACSBy Delivery Model, market is segmented into:

Cloud/ web based modelsOn-premise modelsOthers

The company profiles also covers the detailed description and segmentation of the companies along the finances which are being covered for the company. The global Opthalmology Pacs market is likely to provide insights for the major strategies which is also estimated to have an impact on the overall growth of the market. Several strategies such as the PESTEL analysis and SWOT analysis is also being covered for the global market. These strategies have an impact on the overall market. Furthermore, several factors such as the emergence of new opportunities is also likely to boost the growth of the market. In addition, the market research provides several detailed analysis for the market which has an impact for the end user.

The Opthalmology Pacs market report also comprises business augmentation projects, retailers, consumers, the Opthalmology Pacs market deals network, suppliers, data sources, research findings, as well as reference section. The market study on the global Opthalmology Pacs market also gives in-depth research regarding the market share, market conditions, and market segmentation. Moreover, this research study focuses on the broad landscape of this market with its progress prospects over the forecast period. Additionally, the research study also encompasses a discussion of the leading players operating in the global Opthalmology Pacs market. Likewise, the study also covers the several major regions such as Europe, Asia Pacific, North America, and MEA.

For Any Query on the Opthalmology Pacs Market: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/608

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414

The rest is here:
Opthalmology Pacs Market 2020 Growth Analysis, Current Demand, Research Study, Regions, Types and Key Companies Overview till 2025 - Market Research...

Sunlight is essentially radiation from the sun that makes its way to earth. This radiation, commonly referred to as sunlight, is what lights and warms the earth and facilitates life all across the planet.

Even at night, the light we call moonlight is simply a reflection of the radiant energy emanating from the sun. But sunlight is far more than the rays we perceive as light with our eyes. Beyond what our eyes can register, other rays such as ultraviolet rays, are also a part of what the sun sends our way.

Ultraviolet radiation is a form of non-ionizing radiation that comes from sunlight and various artificial sources such as tanning beds, the mercury vapor lighting often found in high school gymnasiums, as well as halogen, fluorescent and incandescent lights. Different types of ultraviolet radiation can also be generated by welding machines and other sources. In short, ultraviolet radiation is in most environments where human beings might find themselves. And just like light, ultraviolet radiation also reflects of off surfaces such as water, glass, and even snow.

Among the many things which ultraviolet rays contribute to or cause are the premature aging and loss of elasticity in skin and skin cancer. These are possible regardless of skin type or color, and though many might believe darker skin is a protection from ultraviolet rays, any protection it affords is minimal. The conventional wisdom that a good suntan protects us from the harmful effects of sunlight isnt as accurate as you might think. It merely shows less, and the damage is not as readily apparent on tanned or darker skin as it may be on untanned or fairer skin tones.

The damage caused is typically slower in becoming obvious; even a serious sunburn will fade or peel and be replaced by new skin. And the effects do not stop at skin, either. Serious and/or continuous exposure to harmful ultraviolet rays is listed as a causative factor in many eye conditions and diseases. Macular degeneration, inflamed corneas, pterygium and cataracts are caused or made worse by UV exposure.

Ultraviolet rays can put you at increased risk for cataracts and macular degeneration, said Stephanie Sizemore, a triage technician at Ashland Opthalmology. Sizemore said this is especially true if you happen to have a fair complexion or if youre outside for an extended period of time each day. When you are outside, especially for long periods of time, you need to be wearing sunglass with at least a 400 UV rating. And if you work outside, you definitely need to be wearing them.

Sizemore said that artificial sources of ultraviolet radiation are equally as dangerous as the rays found in sunlight, and can be more dangerous when concentrated.

I know Dr. Daniels here does not recommend any sort of tanning beds, Sizemore said. The concentration of ultraviolet light is unhealthy for both the skin and the eyes, and it is difficult to completely protect the eyes under tanning bed conditions. Most people are not going to be exposed to arc or other types of welding machines, but she stressed the importance of the proper eye protection for those individuals who are required to use them.

The difference is you notice damage from machines right away, Sizemore said. Welders talk about getting flash-burned and you notice that almost immediately.

There are also related issues which can be complicated due to overexposure and sometimes occasional exposure to ultraviolet rays, Sizemore said. When you are dealing with diabetes, for instance, one of the things you have to worry about is diabetic retinopathy, which is basically leaky blood vessels at the back of the eye. And overexposure can affect that as well. Reflected UV rays are pretty much just as bad as direct exposure, so you need to be careful to wear eye protection any time you are around reflected ultraviolet rays.

Nearly every health professional today will recommend that individuals limited extended (unprotected) exposure to the sun whether considering skin or eyes. Use sunscreen and 400-plus rated protection sunglasses, and use a wide-brimmed hat when not able to limit the exposure. This doesnt mean that we cant get out and have a good time in the sun; it is just that most health professionals recommend limited over extended exposure, and regular eye exams and doctors visits.

We are making critical coverage of the coronavirus available for free. Please consider subscribing so we can continue to bring you the latest news and information on this developing story.

See the original post:
Protection under the sun | News | dailyindependent.com - The Independent